Hi All - Hope you didn't today's AdPromo WG presentation but if you did, the slides are posted in the Resources (and, linked herein). We covered a bunch of topics today (see below) but ran out of time for the Q&A on the Enforcement Insights topic. No worries... Mark and Bob will join us at the Nov 17th WG meeting and take questions then... So, jot down your questions and mark your calendar for Nov 17 @ 12 pm ET.
Covered today:
- OPDP Proposed Research – More on Disclosures (secondary claims and biosimilars)
- OPDP Research Published - Physician Interpretation of Data of Uncertain Clinical Utility in Oncology Rx Drug Promotion
- A Glimpse at OPDP Metrics
- Bad Ad Quiz – How did you do?
- 'TGA approved' must not be used in advertising
- Presentation of RWE Data - Lessons Learned - Krystapher Belton/New Product Commercialization Extern, Mallinckrodt Pharmaceuticals, Purdue College of Pharmacy
- Enforcement Letters – Q&A on The Process and Insights -Bob Dean (Merck) & Mark Gaydos (Sanofi)